PTC Therapeutics, Inc.
PTCT· Nasdaq
Released Feb 28, 2019, after the close
10-K filed Mar 1, 2019, 60 days after period end · 0001070081-19-000018
| Metric | Q4 2018 | Q4 2017 | Q4 2016 | Q4 2015 |
|---|---|---|---|---|
| Revenue | $85.83M | $57.95M | $25.12M | $12.73M |
| Net Income | -$48.33M | $1.27M | -$26.80M | -$50.95M |
| EPS Diluted |
PTC Therapeutics, Inc. · CIK 1070081 · Engraved from SEC EDGAR
| $0.96 |
| $0.03 |
| -$0.78 |
| -$1.50 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.